Reports

Interim reports

Interim report Q3 2018 statement

Annual reports

2018, First half
2017

Year-end reports

Year-end Report 2018

Memorandum

Memorandum for Scandion Oncology

 

Scandion Oncology Investor Relations

Nils Brünner, CEO
E: nb@scandiononcology.com
T: +45 26144708

Investor Relations

Spotlight
Waterfront Building
Klarabergsviadukten 63, 9 tr
101 23 Stockholm
Sweden

Phone: +46 8 511 68 000
Website: www.spotlightstockmarket.com

Qualified Adviser

Sedermera Fondkommission
Norra Vallgatan 64
211 22 Malmö
Sweden

Phone: + 46 406151410
Website: www.sedermera.se

Privacy and Cookie Policy